Clarithromycin and Malarone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clarithromycin and Malarone. Common interactions include diarrhoea among females and drug rash with eosinophilia and systemic symptoms among males.

The phase IV clinical study analyzes what interactions people who take Clarithromycin and Malarone have. It is created by eHealthMe based on reports of 8 people who take Clarithromycin and Malarone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

8 people who take Clarithromycin and Malarone together, and have interactions are studied.


What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 39,342 Clarithromycin users for its effectiveness, alternative drugs and more.

What is Malarone?

Malarone has active ingredients of atovaquone; proguanil hydrochloride. It is often used in malaria. eHealthMe is studying from 3,021 Malarone users for its effectiveness, alternative drugs and more.

Number of Clarithromycin and Malarone reports submitted per year:

Clarithromycin and Malarone drug interactions.

Common Clarithromycin and Malarone drug interactions by gender *:

female:

  1. Diarrhoea
  2. Drug exposure during pregnancy
  3. Fatigue
  4. Formication
  5. Gastrointestinal malformation
  6. Pyrexia
  7. Sensory disturbance
  8. Abdominal pain
  9. Anal atresia
  10. Asthenia

male:

  1. Drug rash with eosinophilia and systemic symptoms
  2. Pemphigoid
  3. Cholestasis
  4. Cough
  5. General physical health deterioration
  6. Lymphadenopathy
  7. Pyrexia

Common Clarithromycin and Malarone drug interactions by age *:

0-1:

  1. Drug exposure during pregnancy
  2. Gastrointestinal malformation
  3. Anal atresia

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug rash with eosinophilia and systemic symptoms
  2. Abdominal pain
  3. Cholestasis
  4. Cough
  5. Diarrhoea
  6. General physical health deterioration
  7. Lymphadenopathy
  8. Pyrexia

60+:

  1. Pemphigoid

* Approximation only. Some reports may have incomplete information.

Do you take Clarithromycin and Malarone?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Clarithromycin and Malarone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Clarithromycin interactions:

Browse all interactions between Clarithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin and atovaquone; proguanil hydrochloride (the active ingredients of Clarithromycin and Malarone, respectively), and Clarithromycin and Malarone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Clarithromycin and Malarone.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: